These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 8576280
21. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study. Lanza G, Gafà R, Santini A, Maestri I, Dubini A, Gilli G, Cavazzini L. Cancer; 1998 Jan 01; 82(1):49-59. PubMed ID: 9428479 [Abstract] [Full Text] [Related]
22. [Analysis of the malignant potentiality in superficial esophageal carcinoma by cytofluorometry of nuclear DNA and cellular protein contents--in relation to histopathologic findings and prognosis]. Nakamura T. Nihon Kyobu Geka Gakkai Zasshi; 1992 Feb 01; 40(2):242-52. PubMed ID: 1593164 [Abstract] [Full Text] [Related]
23. [Relationship between DNA ploidy and survival in breast cancer]. Utada Y, Yoshimoto M, Kasumi F, Akiyama F, Sakamoto G. Gan To Kagaku Ryoho; 1998 Apr 01; 25 Suppl 3():431-5. PubMed ID: 9589048 [Abstract] [Full Text] [Related]
24. Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone? Currin SM, Lee SE, Walther PJ. J Urol; 1990 Mar 01; 143(3):458-63. PubMed ID: 2304153 [Abstract] [Full Text] [Related]
25. Study of the DNA content by flow cytometry and proliferation in 281 brain tumors. García R, Bueno A, Castañon S, Ruiz-Barnes P, Maria de Campos J, Kusak E, Fortes JR, Ortiz F, Sarasa JL. Oncology; 1997 Mar 01; 54(2):112-7. PubMed ID: 9075781 [Abstract] [Full Text] [Related]
26. Nuclear DNA analysis: the relevance of ploidy, DNA heterogeneity and phases of the cell cycle in 329 patients with prostatic carcinoma. A study on a follow-up of eight years. al-Abadi H, Nagel R. Urol Int; 1990 Mar 01; 45(6):350-5. PubMed ID: 2288053 [Abstract] [Full Text] [Related]
27. The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 100 untreated cases. Tribukait B, Gustafson H, Esposti PL. Br J Urol; 1982 Apr 01; 54(2):130-5. PubMed ID: 7082931 [Abstract] [Full Text] [Related]
29. Nuclear DNA profiles in primary melanomas and their metastases. Rode J, Williams RA, Charlton IG, Dhillon AP, Moss E. Cancer; 1991 May 01; 67(9):2333-6. PubMed ID: 2013040 [Abstract] [Full Text] [Related]
32. Prognostic value of DNA ploidy status in patients with rectal cancer. Berczi C, Bocsi J, Bartha I, Math J, Balazs G. Anticancer Res; 2002 May 01; 22(6B):3737-41. PubMed ID: 12552986 [Abstract] [Full Text] [Related]
35. Prognostic factors in medulloblastoma, including DNA ploidy. Zerbini C, Gelber RD, Weinberg D, Sallan SE, Barnes P, Kupsky W, Scott RM, Tarbell NJ. J Clin Oncol; 1993 Apr 01; 11(4):616-22. PubMed ID: 8478656 [Abstract] [Full Text] [Related]
36. Nuclear DNA content, proliferation index, and nuclear size determination in normal and cirrhotic liver, and in benign and malignant primary and metastatic hepatic tumors. Deprez C, Vangansbeke D, Fastrez R, Pasteels JL, Verhest A, Kiss R. Am J Clin Pathol; 1993 May 01; 99(5):558-65. PubMed ID: 8493949 [Abstract] [Full Text] [Related]
37. [Studies on nuclear DNA content in bladder cancers using flow cytometry]. Toyota K. Hokkaido Igaku Zasshi; 1996 Jan 01; 71(1):45-53. PubMed ID: 8727374 [Abstract] [Full Text] [Related]
39. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder. Deliveliotis C, Georgoulakis J, Skolarikos A, Trakas N, Varkarakis J, Albanis S, Protogerou B, Bamias A. Urol Res; 2005 Feb 01; 33(1):39-43. PubMed ID: 15258707 [Abstract] [Full Text] [Related]